Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G K Dresser

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Investigation|December 4, 2003
The effects of fruit juices on drug disposition: a new model for drug interactionsG K Dresser, D G Bailey
Clinical Pharmacology and Therapeutics|June 29, 2000
Grapefruit juice-lovastatin interactionD G Bailey, G K Dresser
Clinical Pharmacology and Therapeutics|August 17, 2000
Grapefruit juice--felodipine interaction in the elderlyG K Dresser, D G Bailey, S G Carruthers
Clinical Pharmacokinetics|February 11, 2000
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibitionG K Dresser, J D Spence, D G Bailey
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 20, 2003
Bioavailability of omega-3 essential fatty acids from perilla seed oilE M Kurowska, G K Dresser, L Deutsch, et al.
Clinical Pharmacology and Therapeutics|February 16, 2007
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juiceD G Bailey, G K Dresser, B F Leake, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredientsD G Bailey, G K Dresser, J H Kreeft, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Red wine-cisapride interaction: comparison with grapefruit juiceE M Offman, D J Freeman, G K Dresser, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|March 8, 2016
Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel DiseaseB Al-Judaibi, U I Schwarz, N Huda, et al.
Clinical Pharmacology and Therapeutics|March 30, 2007
Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinololU I Schwarz, H Hanso, R Oertel, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Investigation|December 4, 2003
The effects of fruit juices on drug disposition: a new model for drug interactionsG K Dresser, D G Bailey
Clinical Pharmacology and Therapeutics|June 29, 2000
Grapefruit juice-lovastatin interactionD G Bailey, G K Dresser
Clinical Pharmacology and Therapeutics|August 17, 2000
Grapefruit juice--felodipine interaction in the elderlyG K Dresser, D G Bailey, S G Carruthers
Clinical Pharmacokinetics|February 11, 2000
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibitionG K Dresser, J D Spence, D G Bailey
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 20, 2003
Bioavailability of omega-3 essential fatty acids from perilla seed oilE M Kurowska, G K Dresser, L Deutsch, et al.
Clinical Pharmacology and Therapeutics|February 16, 2007
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juiceD G Bailey, G K Dresser, B F Leake, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredientsD G Bailey, G K Dresser, J H Kreeft, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Red wine-cisapride interaction: comparison with grapefruit juiceE M Offman, D J Freeman, G K Dresser, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|March 8, 2016
Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel DiseaseB Al-Judaibi, U I Schwarz, N Huda, et al.
Clinical Pharmacology and Therapeutics|March 30, 2007
Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinololU I Schwarz, H Hanso, R Oertel, et al.
Pageof 2